On the recordJuly 27, 2011
Is it alarming to you that American companies would choose not to seek American approval for breakthroughs that they have?
Source
congress.govEditor's note · Context
Burr questions the trend of companies bypassing U.S. drug approvals.
Share & report
More from Richard Burr
Jun 15, 2022
I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.
Jun 15, 2022
I always like to bring things back to the present because I have a tremendous amount of respect for all four of you.
Apr 4, 2022
The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.
Other voices in this conversation
